Evotec SE (EVO) Cash & Current Investments (2009 - 2026)
Evotec SE's (EVO) quarterly Cash & Current Investments came in at $425.9 million in Q2 2026, up 36.21% year-over-year from $312.7 million in Q2 2025, and down 10.61% quarter-over-quarter from $476.4 million in Q1 2026.
Analysis
Evotec SE (EVO) Cash & Current Investments (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Cash & Current Investments across 10 years of filings, most recently posting $425.9 million for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 36.21% year-over-year to $425.9 million; the TTM figure through Jun 2026 stood at $425.9 million (up 36.21% YoY), while the FY2025 annual figure was $495.7 million, up 47.41% from the prior year.
- Cash & Current Investments came in at $425.9 million for Q2 2026 at Evotec SE, down from $476.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $746.9 million in Q2 2022 to a low of $209.9 million in Q3 2025.
- Average Cash & Current Investments over 5 years is $457.4 million, with a median of $472.9 million recorded in 2022.
- Year-over-year, Cash & Current Investments tumbled 45.61% in 2022 and jumped 54.77% in 2026.
- Over 5 years, Cash & Current Investments stood at $435.3 million in 2022, then advanced by 29.44% to $563.4 million in 2023, then sank by 41.08% to $332.0 million in 2024, then soared by 53.83% to $510.7 million in 2025, then fell by 16.61% to $425.9 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $425.9 million in Q2 2026, $476.4 million in Q1 2026, and $510.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.08 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 192.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 425.88 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.40 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 425.88 Mn |
| Mar 31, 2026 | 476.41 Mn |
| Dec 31, 2025 | 510.71 Mn |
| Sep 30, 2025 | 209.92 Mn |
| Jun 30, 2025 | 312.67 Mn |
| Mar 31, 2025 | 307.83 Mn |
| Dec 31, 2024 | 331.99 Mn |
| Sep 30, 2024 | 336.65 Mn |
| Mar 31, 2024 | 474.91 Mn |
| Dec 31, 2023 | 563.44 Mn |
| Jun 30, 2023 | 513.84 Mn |
| Dec 31, 2022 | 435.29 Mn |
| Sep 30, 2022 | 472.92 Mn |
| Jun 30, 2022 | 746.95 Mn |
| Mar 31, 2022 | 741.55 Mn |
| Dec 31, 2021 | 800.31 Mn |
| Sep 30, 2021 | 404.56 Mn |
| Dec 31, 2020 | 516.60 Mn |
| Dec 31, 2019 | 306.65 Mn |
| Sep 30, 2010 | 27.63 Mn |